Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Fulgent Genetics Q2 2025 Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Fulgent Genetics Inc. (FLGT)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,442,262 | $28,672,169 | -27% | 0.01% |
| 2. | Citadel Investment Group Ken Griffin | 603,653 | $12,000,621 | +39% | 0% |
| 3. | Point72 Asset Management Steve Cohen | 544,877 | $10,832,155 | +1406% | 0.02% |
| 4. | D E Shaw D. E. Shaw | 476,488 | $9,472,581 | +9% | 0.01% |
| 5. | Tudor Investment Corp Paul Tudor Jones | 185,088 | $3,679,549 | +289% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.96 | 100,000 | $1,596,470.00 | 348,282 | 2025-03-05 | Filing | |
| $4.95 | 8,739 | $43,239.70 | 6,579,326 | 2019-03-05 | Filing | |
| $3.59 | 10,880 | $39,032.00 | 6,570,587 | 2018-11-13 | Filing | |
| $3.36 | 10,000 | $33,610.00 | 6,559,707 | 2018-11-09 | Filing | |
| $3.60 | 1,000 | $3,604.20 | 1,000 | 2017-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.03 | 1,063 | $23,414.38 | 957,085 | 2025-09-03 | Filing | |
| $22.03 | 1,128 | $24,846.12 | 364,121 | 2025-09-03 | Filing | |
| $21.48 | 1,199 | $25,760.16 | 365,249 | 2025-08-27 | Filing | |
| $21.48 | 943 | $20,260.07 | 958,148 | 2025-08-27 | Filing | |
| $21.50 | 696 | $14,965.11 | 366,448 | 2025-08-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,162,545 | $42,991,404 | 0% | |
| 2. | 1,165,959 | $23,179,264 | 0% | |
| 3. | 1,134,422 | $22,551,841 | 0.01% | |
| 4. | 513,797 | $10,214,284 | 0% | |
| 5. | 513,343 | $10,206,944 | 0% |
News See All
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2025 Earnings Call Transcript
Melanie Solomon: Greetings and welcome to the Fulgent Genetics, Inc. Q1 2025 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Fulgent Genetics, Inc. Q4 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Fulgent Genetics Q3 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2024 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q2 2024 Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.33. Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.28, expectations were $-0.3. Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Fulgent Genetics Q3 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
Hedge Fund Resource Center Billionaire Hedge Funds
